中国经济网北京12月18日讯蓝思科技（300433）(300433.SZ)今日收报28.59元，跌幅3.58%。 蓝思科技12月10日发布关于签订股权收购意向协议的公告。蓝思科技股份有限公司(以下简称"公司")于 2025年12月10日在中国香港与吕松寿LEU,SONG-SHOW签订了《股权收购意向协议》，拟以现金及其 他合法方式购买吕松寿LEU,SONG-SHOW拥有的PMGInternationalCo.,LTD.(裴美高国际有限公司)100% 股权。 具体交易金额、交易方案等将由相关各方根据尽职调查、审计及评估结果等进一步协商谈判，具体交易 金额及收购方式将由交易双方在正式收购协议中确定。 蓝思科技12月11日盘中股价最高至32.78元，至今日为止股价累计跌幅12.78%。 ...

Core Insights - The company, Jinfu Technology, has announced that its production capacity is fully utilized and has completed a new round of expansion, with production expected to commence before the Spring Festival [1] - The company has achieved a shipment scale of tens of millions in cold plates and related products, and anticipates an increase in order volume after the new production line is operational by the end of the year [1] Company Developments - Jinfu Technology's production capacity is currently at full capacity, indicating strong demand for its products [1] - The company has successfully completed its expansion efforts, which will enhance its production capabilities [1] - The expected increase in order volume post-expansion suggests positive growth prospects for the company [1]

格隆汇12月17日丨长盈精密(300115.SZ)在互动平台表示，公司在高速连接器产品可满足PCIe Gen5/Gen6 性能，处于国际领先水平。 ...

Group 1 - The company, Changying Precision (300115.SZ), has stated on its interactive platform that it has not yet ventured into the elderly care-related business [1]

Core Viewpoint - Shanghai Tongchuang Purun New Materials Co., Ltd. focuses on the research and production of high-purity metal materials required for integrated circuit manufacturing, becoming a key supplier for leading global chip manufacturers and supporting the production of AI chips and high-end electronic products [1][2]. Company Overview - Established on January 7, 2021, with a registered capital of 287.35 million yuan, the company is led by controlling shareholder Yao Shun, who holds 17.61% of the shares [1]. - The company specializes in high-purity materials such as 6N aluminum, 6N tantalum, 7N copper, and 5N manganese, which are essential for advanced chip manufacturing processes [1][2]. Production and Technology - In 2023, the company achieved large-scale production of ultra-high-purity manganese, becoming the second company globally capable of mass production of this material [2]. - The core materials required for 3nm advanced process chips include ultra-high-purity aluminum, copper, tantalum, manganese, and alloys, with purity levels reaching 5N or even 7N [2]. - The sputtering target materials produced by the company are used to form nano-level circuit interconnections in chip manufacturing [2]. Market Position and Strategy - The sputtering target material industry has historically been dominated by foreign companies, but the company is actively developing next-generation material technologies to meet the challenges of advanced processes driven by AI and high-performance computing [2]. - The company has established seven industrial bases globally and has over 700 employees, with more than 200 patents accumulated [2]. Financing and Investment - Since its establishment, the company has completed five rounds of equity financing, with the latest being a Pre-IPO round in September 2025, raising nearly 200 million yuan [2][3]. - In August 2025, the company completed an A+ round financing exceeding 1 billion yuan, with participation from various investment institutions [3][4]. Strategic Partnerships - The company has formed a deep strategic collaboration with Jiangfeng Electronics, serving as a core supplier of high-purity metal materials and supporting supply chain security and production continuity [5]. - Joint technical efforts are underway to develop and mass-produce ultra-high-purity aluminum, copper, and manganese sputtering targets, which have been certified and integrated into the supply chains of international mainstream chip manufacturers [5].

Core Viewpoint - Kosen Technology is facing scrutiny over its decision to sell its profitable subsidiary, Kosen Medical, amid ongoing losses, raising questions about the company's future strategic direction and operational viability [1][2]. Group 1: Company Strategy and Financial Performance - Kosen Technology plans to sell Kosen Medical for 915 million RMB, achieving a significant valuation increase of 206.45%, which is intended to enhance its financial performance [1]. - The company has reported consecutive losses for two years, with projected net losses of 281 million RMB in 2023 and 477 million RMB in 2024, indicating ongoing financial challenges [2]. - The sale is part of a broader strategy to optimize business operations and restructure finances, aiming to return to profitability while focusing on high-growth areas such as thermal management modules and robotic components [2]. Group 2: Investor Concerns and Transparency - Investors express concerns regarding the potential impact of asset sales on their interests, questioning the rationale behind selling a profitable asset during a period of financial distress [2]. - Kosen Technology is urged to improve transparency in its disclosures, providing detailed information about the transaction, including valuation methods and expected future benefits, to reassure investors [2]. - The company is also advised to strengthen its strategic planning and clarify the pathways and expected returns of new business initiatives to build investor confidence in its future direction [2][3].

Core Viewpoint - Kosen Technology announced that it received a regulatory letter from the Shanghai Stock Exchange regarding the sale of its wholly-owned subsidiary Kosen Medical's equity, highlighting concerns over the company's ongoing losses while the subsidiary reported revenue and profit [1] Financial Performance - Kosen Medical achieved revenues of 366 million yuan and 354 million yuan for the first three quarters of 2024 and 2025, respectively [1] - The net profits for Kosen Medical were reported at 41.12 million yuan and 47.24 million yuan for the same periods [1] - In contrast, the parent company continues to incur losses during this timeframe [1] Regulatory Requirements - The exchange has requested the company to provide additional disclosures, including the reasons for the losses and the financial impact of the transaction [1] - An independent board member's interviews and document reviews found no evidence of related party transactions or undisclosed interests in the deal [1] Internal Transactions - A special audit covering the period from 2018 to September 30, 2025, confirmed that transactions between Kosen Medical and the parent company, as well as its subsidiaries, were necessary, reasonably priced, and had commercial substance [1]

Core Viewpoint - The legal dispute between Chongqing Taiguan Technology Co., Ltd. and Simat Technology Co., Ltd. has been resolved, resulting in a financial settlement that positively impacts the company's profits for the current year [1] Summary by Relevant Sections - **Legal Proceedings**: Chongqing Taiguan initiated a lawsuit against Simat due to a sales contract dispute, leading to a court ruling that required Simat to pay $926,200 for equipment and additional penalties totaling $123,500, along with legal fees of 50,000 RMB [1] - **Appeal and Enforcement**: After Simat appealed the ruling, the second-instance judgment upheld the original decision. However, enforcement was complicated as Simat had no assets available for execution, leading to the termination of the enforcement process by the court [1] - **Settlement Agreement**: Following the termination of enforcement, Chongqing Taiguan sought recognition of the mainland court's judgment in Taiwan, resulting in a mediation agreement where Simat is required to pay a total of $400,000 in two installments by October 30, 2025 [1] - **Financial Impact**: The resolution of this case allowed Chongqing Taiguan to reverse a previously established impairment provision of 1.59 million RMB, resulting in an increase in profits for the current fiscal year by the same amount [1]

天眼查App显示，近日，厦门永祥裕电子有限公司成立，法定代表人为黄芳强，注册资本100万人民 币，经营范围为一般项目：电子产品销售；机械零件、零部件销售；金属结构销售；电力电子元器件销 售；电子元器件零售。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）许可项目：国 营贸易管理货物的进出口。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项 目以相关部门批准文件或许可证件为准）。 ...

Core Viewpoint - The company, through its wholly-owned subsidiary Ningbo Shangrong Logistics Co., Ltd., has established a joint venture investment fund with a professional institution, indicating a strategic move to diversify its investment portfolio and engage in the technology sector [1] Group 1: Company Actions - Ningbo Shangrong has invested RMB 100 million to form a joint venture with Suzhou Industrial Park Lanpu Venture Capital Management Partnership, creating the Suzhou Industrial Park Xincheng Venture Capital Partnership [1] - Ningbo Shangrong holds a 55.60% investment share in the newly established Suzhou Xincheng fund [1] Group 2: Market Developments - Beijing Angrui Microelectronics Technology Co., Ltd. is set to go public on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 16, 2025, with a total of 24,882,922 shares being issued [1] - After the IPO, the total share capital of Angrui Microelectronics will be 99,531,688 shares [1] Group 3: Investment Holdings - Suzhou Xincheng holds 257,706 shares of Angrui Microelectronics, representing 0.2589% of the total share capital post-IPO [1] - The shares held by Suzhou Xincheng are subject to a 12-month transfer restriction from the date of Angrui Microelectronics' listing [1]